BDRX (BDRX) Stock Price & Analysis
BDRX (BDRX) fell 1.79% to USD 1.65 as of July 25, 2026 at 03:07 UTC, according to Nexqual real-time market data.
BDRX last closed at USD 1.68; the session ranged USD 1.64–1.85 on volume of 63,497 shares. Market capitalization is $1.49M, with a 52-week range of USD 1.64–59.4 (NCM). Source: Nexqual, July 25, 2026 at 03:07 UTC.
Key Statistics (as of July 25, 2026 at 03:07 UTC)
| Price | USD 1.65 |
|---|---|
| Change | ▼ 1.79% (down) |
| Previous Close | USD 1.68 |
| Open | USD 1.81 |
| Day Range | USD 1.64 – 1.85 |
| 52-Week Range | USD 1.64 – 59.4 |
| Volume | 63,497 shares |
| Market Cap | $1.49M |
| Exchange | NCM |
Technical Analysis (BDRX)
Nexqual's technical model rates BDRX "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:07 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 15.26 (oversold) |
| vs SMA50 | Below (USD 2.86) |
| MACD | -0.35 (negative) |
Analyst Ratings (BDRX)
Wall Street analysts rate BDRX "None" based on 1 analysts, with a mean price target of USD 10.05 (range USD 10.05–10.05), per Nexqual as of July 25, 2026 at 03:07 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 10.05 |
| High Target | USD 10.05 |
| Low Target | USD 10.05 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (BDRX)
| EPS Estimate | USD 0 |
|---|---|
| Revenue Estimate | $0 |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Financials & Fundamentals (BDRX)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -64.72% |
| Debt / Equity | 0.54 |
| Current Ratio | 2.03 |
| Total Cash | $8.53M |
| Total Debt | $61,000 |
| Free Cash Flow | $-1.00M |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Financial Health Score (BDRX)
Nexqual rates BDRX's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $9M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$6M |
| Efficiency | Critical — ROE -65%, ROA -32.8% |
Ownership (BDRX)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +9.19% |
| Shares Outstanding | 904,066 |
| Float | 605,875 |
| Short % of Float | +9.02% |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Leadership (BDRX)
BDRX is led by Fiona Mary Powell (age 57), Company Secretary, CFO & Director, per Nexqual as of July 25, 2026 at 03:07 UTC.
| Company Secretary, CFO & Director | Fiona Mary Powell (age 57) |
|---|---|
| Vice President of Technology | Daniel Palmer |
Major Backers & Investors (BDRX)
Notable institutional backers of BDRX include Sabby Management, LLC, Armistice Capital, LLC, Gamma Investing LLC, according to Nexqual as of July 25, 2026 at 03:07 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Sabby Management, LLC | 6.9% |
| Armistice Capital, LLC | 2.61% |
| Gamma Investing LLC | 0.16% |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TNON | Tenon Medical, Inc. | USD 0.19 | ▼ 3.65% |
| FRGT | Freight Technologies, Inc. | USD 3.01 | ▼ 15.45% |
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
| TVGN | Tevogen Bio Holdings Inc. | USD 4.49 | ▲ 5.9% |
| CTNT | Cheetah Net Supply Chain Servic | USD 1.73 | ▲ 11.61% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:07 UTC. This page is informational and not investment advice.